To Begin Your Climb to a Cannabis Investing Fortune, Start Right Here

Please do not reply to this message, as replies are routed to an unmonitored mailbox. You are receiving this email as a part of your subscription to Cannabis Profits Daily. If you have any questions or would like to change your email settings, please reference the contact information at the bottom of this email.

Dear Reader, Welcome back to Cannabis Profits Daily. We're constantly adding new content to our website, NICinvestors.com. We hope you'll take a stroll around and check out the various features available to investors based on their level of membership with the National Institute for Cannabis Investors. A question I hear a lot when talking to folks is simply: "If I'm new to cannabis investing, where do I start?" Not to worry, Cannabis Profits Daily has you covered. You're obviously interested in generating potentially life-changing wealth from cannabis stocks, so start out with our Cannabis Investor's Primer. This is your guide to get on the road to life-changing investment decisions. In this Primer, I'll show you the six most common types of cannabis companies you can capitalize on before the federal government ends cannabis prohibition for good. And, if you listened to former U.S. House Speaker John Boehner during the American Cannabis Summit, that's coming in less than five years. What excites me most right now as NICI's executive director is helping everyday investors learn about this opportunity before the big players predictably flood the market. In any other industry, it's the Vanguard's, the BlackRock's, and the Morgan Stanley's who shape the markets with their billion-dollar investment decisions. But right now, federal prohibition in the United States has the biggest banks and major hedge funds stuck on the sidelines in the fast-growing cannabis market. And with these "market makers" relegated to the sidelines, individual investors actually possess a huge edge over the institutional money. But this advantage won't last forever. So, I urge you to click the following link and read through this Primer as soon as you have a second. Thanks for being an important part of the National Institute for Cannabis Investors, Greg Miller Executive Director, National Institute for Cannabis Investors P.S.: I'll be back later this week to tell you about more valuable research that we'll be releasing to you at no charge. Stay tuned... You are receiving this e-mail at ITS028@gmail.com, as a part of your subscription. Remove your email from this list: Unsubscribe © 2019 The National Institute for Cannabis Investors All Rights Reserved The National Institute for Cannabis Investors | 1125 N Charles Street | Baltimore, MD 21201 Toll Free: 866.260.0361; International: 410.777.8270 Contact Customer Service Website: https://nicinvestors.com Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your financial adviser and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This information may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The National Institute for Cannabis Investors, 1125 N Charles Street, Baltimore, MD 21201. Privacy Policy | Terms & Conditions